Skip to Main Content

Paper Details

Human-specific polymorphic pseudogenization of <i>SIGLEC12</i> protects against advanced cancer progression.
FASEB Bioadv
13
2020
Human, PC-3 prostate cancer cells, SIGLEC12, SIGLEC12 allele, SIGLEC12 gene, SIGLEC12 null carcinoma cell line, Shp2, Shp2-dependent, Siglec-XII, Siglec-XII protein, advanced carcinomas, cancer, cancers, cancers arising, carcinoma, carcinomas, colorectal cancers, epithelial cells, genes, genomes, human, human urinary epithelial cells, humans, mouse, pseudogene, sialic acid, tumor
Author NameAffiliation
Teresa L Johnson-PaisDepartment of Urology University of TX Health Science Center San Antonio TX USA.
Robin J LeachDepartment of Urology University of TX Health Science Center San Antonio TX USA.
Robin J LeachDepartments of Cell Systems and Anatomy University of TX Health Science Center San Antonio TX USA.
Charles WangSchool of Public Health Loma Linda University Loma Linda CA USA.
Gen-Sheng FengGlycobiology Research and Training Cente and Center for Academic Research and Training in Anthropogeny University of California San Diego CA USA.
  • 1 - 5

Datasets

Release 1.2